Xconomy

DECEMBER 10, 2018

The San Diego chipmaker said a Chinese court has ordered four Apple (NASDAQ: AAPL ) subsidiaries in China to stop the sale and import of seven iPhone models in that country. Qualcomm announced a win Monday in its ongoing and multijurisdictional legal battle with Apple.

Sales 45

Sales San Diego Patents Screening 45

Xconomy

NOVEMBER 13, 2016

I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. Tim Rueth, a UC San Diego entrepreneur in residence and member of the EvoNexus selection committee, also screened the list, and offered his perspective.

San Diego 40

San Diego Technical Review Artificial Inteligence Startup 40

Xconomy

JUNE 24, 2020

San Diego-based La Jolla (NASDAQ: LJPC ) has pledged to pay Tetraphase shareholders $43 million in cash now plus another $16 million tied to sales goals for Tetraphase (NASDAQ: TTPH ) antibiotic eravacycline (Xerava). The competition for Tetraphase Pharmaceuticals now has a new winner : La Jolla Pharmaceutical.

San Diego 101

San Diego Competition Sales Develop 101

Xconomy

AUGUST 26, 2020

The San Diego-based company splashed out $52.5 Acadia agreed to pay CerSci shareholders up to $887 million more in payments depending on development, commercialization, and sales milestones, plus royalties. million on the buyout, a cash-and-stock deal—$47.2

San Diego 102

San Diego Acquisition Sales Develop 102

Xconomy

AUGUST 31, 2020

Don’t miss out on savings for this year’s online Xcelerate Keynote Series at Biotech Week Boston – our early bird sale ends this Friday!

Sales 98

Sales Research Conference Product 98

Xconomy

JUNE 26, 2019

The San Diego company said Tuesday that it would sell 2.1 Mirati Therapeutics plans to raise more than $200 million this week in a public offering, funding that it plans to use to advance its lead cancer drug candidate, sitravatinib, into late-stage testing, and to continue developing its other targeted oncology programs.

San Diego 67

San Diego Sales Funding Develop 67

Xconomy

NOVEMBER 26, 2018

Seismic, one of San Diego’s most prominent enterprise software companies, has tapped a member of the team behind one of the region’s most successful tech startup stories to prep for its own prospective market debut. San Diego native John McCauley was part. Read more » Reprints | Share:

San Diego 89

San Diego Sales Software Development Software 89

Xconomy

JULY 26, 2016

In contrast to some alternative lenders, the San Diego firm said it is growing fast and is consistently profitable. LendingClub stumbled earlier this year, however, when an internal investigation found improprieties in the sale of $22 million in loans. Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 40

San Diego Help Software Review Funding 40

Xconomy

MARCH 27, 2019

San Diego-based Acadia (NASDAQ: ACAD ) announced in August that it had licensed the drug, trofinetide, for development and commercialization in North America as a treatment for Rett syndrome and other indications, including Fragile X syndrome. The results of the. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 97

San Diego .Net Sales Develop 97

Xconomy

JULY 7, 2016

Morristown, NJ-based Pernix (NASDAQ: PTX ) will cut 60 workers , mostly from its neurology sales staff, the company said today. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals. As of the end of 2015, Pernix reported a headcount of 274. Last year, Pernix reported a $148.3

Sales 40

Sales San Diego .Net Report 40

Xconomy

DECEMBER 18, 2018

billion sale to Roche , Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies. A year after steering cancer drug developer Ignyta into a $1.7

San Diego 86

San Diego Startup Sales Invest 86

Xconomy

JUNE 24, 2019

Conatus Pharmaceuticals said Monday that it would cut its staff by 40 percent and consider a sale or merger after a drug it was testing as a treatment for an increasingly common form of chronic liver disease failed to beat a placebo in a mid-stage clinical trial—the latest letdown in a number of trial failures.

Sales 70

Sales Company Companies Develop 70

Xconomy

JANUARY 7, 2018

Morgan week—the annual healthcare investment gathering in San Francisco—with a blockbuster deal, acquiring privately-held Impact Biomedicines for $1.1 More is in the offing if Impact’s drug fedratinib passes a series of regulatory and sales hurdles. billion upfront in cash.

San Diego 82

San Diego Sales Invest Help 82

Xconomy

NOVEMBER 5, 2018

Japanese life sciences company Kyowa Hakko Kirin has agreed to pay the San Diego company $10 million upfront for rights to develop and commercialize ME-401 in Japan. million more if the drug, a PI3K delta inhibitor, meets a variety of milestones; plus royalties from sales if it reaches the market.

San Diego 70

San Diego Sales Marketing Develop 70

Xconomy

APRIL 25, 2018

But sales of the landmark drug are slowing, and there is pressure building from rival AveXis (NASDAQ: AVXS ), the Chicago-based. Biogen (NASDAQ: BIIB ) was the first to bring an SMA drug to market, the RNA drug nusinersen (Spinraza), a chronic treatment that has shown an ability to help people with multiple forms of the progressive disease.

Sales 74

Sales Help Marketing San Diego 74

Xconomy

FEBRUARY 1, 2019

Magnolia Medical Technologies , a Seattle-based manufacturer of devices for collecting blood and bodily fluids, announced this week it has raised $20 million in equity funding to ramp up sales of its flagship product. The funding comes as Magnolia and San Diego-based competitor Kurin battle each other in court.

San Diego 64

San Diego News Equity Invest 64

Xconomy

DECEMBER 19, 2017

These innovations run the gamut, including sensors and cameras that can monitor in-store movements, smart fitting rooms that suggest a blouse or pair of shoes to go with the jeans you’re trying on, and robot sales associates that not only remember the dress you bought for that work party, but also to ask how the garment worked out.

Artificial Inteligence 61

Artificial Inteligence Sales Technology Design 61

Xconomy

DECEMBER 14, 2018

The San Diego biotech company, which is testing an antibody discovery platform intended to speed products to patients with cancer and pancreatitis, said Thursday it has retained a local investment banking firm, Objective Capital Partners, to guide its sale. As of Sept.

San Diego 57

San Diego Guide Platform Sales 57

Xconomy

APRIL 25, 2017

In the fiscal year that ended last June, the San Diego maker of respiratory machines for maintaining continuous positive airway pressure (CPAP) generated over $1.8 billion in global sales.

San Diego 74

San Diego Sales Technology Marketing 74

Xconomy

JUNE 27, 2018

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts.

San Diego 61

San Diego Marketing Research Invest 61

Xconomy

DECEMBER 20, 2018

A court in Munich, Germany, has ordered Apple to stop imports and sales in Germany of all models of iPhone that infringe on Qualcomm’s intellectual property, the San Diego wireless giant said Thursday. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Patents 45

Patents San Diego Sales IP 45

Xconomy

SEPTEMBER 14, 2017

The San Diego biotech company’s list of alliances is now getting longer. Depending on the progress of those compounds, Halozyme stands to gain future milestone payments, as well as royalties from sales. The deal covers up to 11 potential drugs, including a class of.

San Diego 64

San Diego Class Sales Technology 64

Xconomy

JUNE 30, 2016

Healthtech entrepreneur Parker Hinshaw and his wife Jean Balgrosky said they intended to take a step back when they founded Bootstrap Incubation near San Diego in the fall of 2012. They came to San Diego in 1996, when Scripps Health hired Balgrosky as CIO and senior vice president. He founded MaxIT Healthcare in 2001.

San Diego 67

San Diego CIO Incubator Startup 67

Xconomy

JUNE 3, 2016

States have been fighting to collect sales taxes from online retailers since the dawn of the e-commerce age. But today, online companies that sell services rather than merchandise also need to be concerned about state sales taxes. For example, medical services are generally not subject to sales tax.

Sales 62

Sales Company Companies Software Review 62

Xconomy

JUNE 16, 2016

In San Diego, the complaints often focus on the relative scarcity of venture capital and hometown VC firms. So when the San Diego Venture Group recruited Mark Suster of Los Angeles-based Upfront Ventures to give the keynote talk Tuesday night for Startup Week San Diego, more than 800 people filled a downtown auditorium.

Venture Capital 49

Venture Capital San Diego Truecar Web 49

Xconomy

DECEMBER 21, 2018

It’s beginning to look a lot like, well, the last roundup of the year, with plenty of news to pack in before our holiday breather.

Pricing 73

Pricing Sales Study News 73

Xconomy

MARCH 20, 2019

A Chicago-based private equity firm has tapped the former head of NuVasive and finance chief of GreatCall to start a new healthcare company in San Diego. The company, Corza Health, is headed by Greg Lucier, most recently CEO at NuVasive, and backed by the PE firm, GTCR, with money from its $5.25 billion Fund XII.

San Diego 62

San Diego Equity Invest Funding 62

Xconomy

NOVEMBER 30, 2016

San Diego-based AttackIQ, a cybersecurity startup providing a Web-based platform for assessing network defenses, has finally closed its Series A round of founding, after raising a total of $8.8 Institutional investors included San Francisco-based Index Ventures , Qualcomm Ventures , and Telstra Ventures.

Tool 40

Tool San Diego Web Platform 40

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. Entrepreneurs at work on first day of Canopy San Diego accelerator program.

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

OCTOBER 10, 2016

By popular acclaim, San Diego-based Echo Laboratories founder Eugene Cho claimed top honors, and a $15,000 check, for his two-minute presentation last week in the 10th annual “Quick Pitch” competition, hosted by San Diego’s Tech Coast Angels. He told the audience Revolve sales had generated $1.8 Echo Labs image).

Tech Coast Angels 40

Tech Coast Angels Technical Review San Diego Software Review 40

Xconomy

AUGUST 1, 2016

PacketSled, a cybersecurity startup based in suburban San Diego, has raised $5 million in a Series A funding round led by Keshif Ventures, a local angel investment fund that has put money into dozens of tech startups in the San Diego area. Two other small funds, Blu Ventures and JHS Ventures joined in the round.

San Diego 40

San Diego Conference Funding Networking 40

Xconomy

APRIL 28, 2017

To judge the first 100 days of a new administration is, as many pundits have pointed out, an odd vestige of history, more convenient than significant. Which is why we’ll start this week’s roundup with our 99-day evaluation of the Trump administration—at least when it comes to healthcare and the life sciences.

Sales 59

Sales Venture Capital San Diego Pricing 59

Xconomy

AUGUST 26, 2019

Four years after approval the two PCSK9 blockers on the market have yet to crack $1 billion in annual sales, combined, thanks to a gloves-off effort by insurers to beat back their use. Far from it. One of the two drugs might even be on life support. Now a third PCSK9 inhibitor is in the ring. Results from a big study are due Sept.

Study 102

Study Conference Sales Marketing 102

Xconomy

MARCH 12, 2018

Orexigen Therapeutics has filed for bankruptcy to sell its weight loss pill to the highest bidder. The news follows years of ups and downs for Orexigen, which piled up debt as it struggled to successfully market its obesity drug, known as Contrave.

Sales 59

Sales News Help Marketing 59

Xconomy

MAY 10, 2019

An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The market for drugs for rare or “orphan” diseases continues to grow.

Pricing 97

Pricing Sales Competition Report 97

Xconomy

AUGUST 22, 2016

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego. We have an endless time horizon.

Develop 40

Develop Development San Diego Startup 40

Xconomy

FEBRUARY 24, 2017

A short week makes for a shorter roundup. As we’ve come to expect, however, there was no dearth of health and life-sciences news from Washington, D.C.

Sales 49

Sales News Funding Artificial Inteligence 49